Faron Pharmaceuticals OY (FARN) NPV
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
- Add to watchlist
- Create an alert
- This stock can be held in a
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
Annual & interim reports
Financial results for the last 5 years
Values are quoted in the stock's local currency: Euro.
Income Statement: | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
---|---|---|---|---|---|
€ (Millions) | € (Millions) | € (Millions) | € (Millions) | € (Millions) | |
Revenue: | n/a | n/a | n/a | n/a | n/a |
Operating Profit / (Loss): | (28.57) | (27.43) | (21.11) | (16.65) | (13.10) |
Net Interest: | (2.38) | (1.30) | (0.07) | (0.28) | (0.15) |
Profit Before Tax: | (30.94) | (28.73) | (21.18) | (16.93) | (13.25) |
Profit after tax from continuing operations: | (30.94) | (28.73) | (21.19) | (16.94) | (13.26) |
Discontinued Operations: | |||||
Profit after tax from discontinuing operations: | n/a | n/a | n/a | n/a | n/a |
Profit for the period: | (30.94) | (28.73) | (21.19) | (16.94) | (13.26) |
Attributable to: | |||||
Equity holders of parent company: | (30.94) | (28.73) | (21.19) | (16.94) | (13.26) |
Minority Interests / Other Equity: | n/a | n/a | n/a | n/a | n/a |
Total Dividend Paid: | c n/a | c n/a | c n/a | c n/a | c n/a |
Retained Profit / (Loss) for the Financial Year: | c n/a | c n/a | c n/a | c n/a | c n/a |
Earnings per Share: | |||||
Basic: | -48.00¢ | -52.00¢ | -42.00¢ | -37.00¢ | -36.00¢ |
Diluted: | -48.00¢ | -52.00¢ | -42.00¢ | -37.00¢ | -36.00¢ |
Adjusted: | -48.00¢ | -52.00¢ | -42.00¢ | -37.00¢ | -36.00¢ |
Dividend per Share: | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
Balance Sheet: | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
€ (Millions) | € (Millions) | € (Millions) | € (Millions) | € (Millions) | |
Assets: | |||||
Non-Current Assets: | |||||
Property, Plant & Equipment: | 0.20 | 0.33 | 0.21 | 0.38 | 0.40 |
Intangible Assets: | 1.09 | 1.15 | 0.90 | 0.56 | 0.53 |
Investment Properties: | n/a | n/a | n/a | n/a | n/a |
Investments: | n/a | n/a | n/a | n/a | n/a |
Other Financial Assets: | n/a | n/a | n/a | n/a | n/a |
Other Non-Current Assets: | 0.06 | 0.06 | 0.05 | 0.06 | 0.08 |
1.35 | 1.54 | 1.16 | 1.00 | 1.00 | |
Current Assets: | |||||
Inventories: | n/a | n/a | n/a | n/a | n/a |
Trade and Other Receivables: | 1.99 | 2.74 | 5.17 | 3.26 | 2.14 |
Cash at Bank & In Hand: | 6.88 | 6.99 | 6.85 | 4.11 | 7.06 |
Current Asset Investments: | n/a | n/a | n/a | n/a | n/a |
Other Current Assets: | n/a | n/a | n/a | n/a | n/a |
8.87 | 9.73 | 12.02 | 7.37 | 9.20 | |
Other Assets: | n/a | n/a | n/a | n/a | n/a |
Total Assets: | 10.22 | 11.27 | 13.18 | 8.37 | 10.21 |
Liabilities: | |||||
Current Liabilities: | |||||
Borrowings: | 3.64 | 2.00 | 0.61 | 0.30 | 0.30 |
Other Current Liabilities: | 11.37 | 8.47 | 6.56 | 6.21 | 5.78 |
15.01 | 10.47 | 7.18 | 6.50 | 6.07 | |
Net Current Assets: | c n/a | c n/a | c n/a | c n/a | c n/a |
Non-Current Liabilities: | |||||
Borrowings: | 9.47 | 11.27 | 2.93 | 2.93 | 2.52 |
Provisions: | n/a | 0.16 | n/a | n/a | n/a |
Other Non-Current Liabilities: | 0.90 | 0.85 | 0.15 | 0.79 | n/a |
10.37 | 12.28 | 3.09 | 3.71 | 2.52 | |
Other Liabilities: | n/a | n/a | n/a | n/a | n/a |
Total Liabilities: | 25.38 | 22.75 | 10.26 | 10.22 | 8.60 |
Net Assets: | (15.16) | (11.48) | 2.92 | (1.85) | 1.61 |
Capital & reserves: | |||||
Share Capital: | 2.69 | 2.69 | 2.69 | 2.69 | 2.69 |
Share Premium Account: | n/a | n/a | n/a | n/a | 78.92 |
Other Reserves: | 154.36 | 129.55 | (116.28) | 92.02 | n/a |
Retained Earnings: | (172.21) | (143.71) | 116.51 | (96.56) | (80.00) |
Shareholders Funds: | (15.16) | (11.48) | 2.92 | (1.85) | 1.61 |
Minority Interests / Other Equity: | n/a | n/a | n/a | n/a | n/a |
Total Equity: | (15.16) | (11.48) | 2.92 | (1.85) | 1.61 |
a. Includes discontinued activities
b. Including assets due in more than one year
c. Not disclosed under IFRS
d. Total fixed assets
e. Includes borrowings
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.